Knott David M Jr »

Nektar Therapeutics shares owned by Knott David M Jr

Quarter-by-quarter ownership of Nektar Therapeutics (NKTR) shares owned by Knott David M Jr from 13F filings

Historical chart of Knott David M Jr investment in Nektar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Nektar Therapeutics held by Knott David M Jr consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Nektar Therapeutics by Knott David M Jr

Quarter filed Position value Share count Share price at filing
2025-12-31 $655k 16k 42.28

More positions owned by Knott David M Jr

Calumet Common (CLMT)
Apollo Global Management Common (APO)
Alphabet Inc-Cl C Common (GOOG)
Syndax Pharmaceutical Common (SNDX)
Xeris Biopharma Holdings Common (XERS)
Travere Therapeutics Common (TVTX)
Bridgebio Pharma Common (BBIO)
Protagonist Therapeutics Common (PTGX)
JPMorgan Chase & Co. Common (JPM)
Janus Henderson AAA CLO ETF Common (JAAA)
Viridian Therapeutics Common (VRDN)
Catalyst Pharmaceuticals Common (CPRX)
Cogent Biosciences Common (COGT)
Mersana Therapeutics Common (MRSN)
Arcus Biosciences Common (RCUS)

View all positions for Knott David M Jr

Top funds holding Nektar Therapeutics

BVF
Susquehanna International
Vanguard Group
Citadel Advisors
Two Seas Capital
BlackRock
Millennium Management
Prosight Management
Invesco
Point72 Asset Management
Sofinnova Ventures
Two Sigma Investments
Emerald Advisers
22NW
Qube Research & Technologies

View all funds holding Nektar Therapeutics